1WA
DNA icon

180 Wealth Advisors’s Ginkgo Bioworks DNA Stock Holding History

180 Wealth Advisors’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-545
Closed -$6.98K – 451
2024
Q2 		$6.98K Sell
545
-96
-15% -$2.86K ﹤0.01% 434
2024
Q1 		$29.7K Buy
641
+4
+0.6% +$207 0.01% 402
2023
Q4 		$42.6K Sell
637
-42
-6% -$2.57K 0.01% 380
2023
Q3 		$49.2K Buy
679
+5
+0.7% +$400 0.01% 368
2023
Q2 		$48K Sell
674
-68
-9% -$4.03K 0.01% 362
2023
Q1 		$39.5K Hold
742
– – 0.01% 362
2022
Q4 		$51.9K Buy
742
+28
+4% +$2.58K 0.01% 363
2022
Q3 		$89K Sell
714
-38
-5% -$4.53K 0.02% 344
2022
Q2 		$72K Buy
752
+93
+14% +$11.3K 0.02% 359
2022
Q1 		$101K Buy
659
+343
+109% +$66.8K 0.02% 365
2021
Q4 		$67K Buy
+316
New +$150K 0.02% 369

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return